Humulin R
Schizo Affective Disorder
Mclean HospitalPhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 89/ 100
Competitive context
11 Active assets in the Schizo Affective Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lorazepam Temple University | Phase 4 | BBB |
Namenda University of California, San Diego | Phase 4 | BB |
Bxcl501 BioXcel Therapeutics Inc | Phase 4 | BB |
Micardis® Xiaoduo Fan | Phase 4 | BB |
il-23 University of Maryland, Baltimore | Phase 4 | BB |
View all 19 →
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →